You are here
Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years
PMID: 15898975 [PubMed - indexed for MEDLINE]
Data pubblicazione:
Saturday, 1 January, 2005
Clin. Exp. Allergy 2005; 35:560–564
Argouments:
